SEOM-GEICO Clinical Guidelines on cervical cancer (2023)
Copyright policy )SEOM-GEICO Clinical Guidelines on cervical cancer (2023)
AbstractCervical cancer (CC) is the fourth most common cancer and the fourth leading cause of mortality in women worldwide. It is strongly associated with high-risk human papillomavirus infection. High-income countries that have implemented human papillomavirus (HPV) vaccination and screening programs have seen dramatic reductions in CC incidence, while developing countries where these programs are not available continue to experience high rates of CC deaths. In early-stage CC, the primary treatment is surgery or radiotherapy, whereas concurrent chemo-radiotherapy (CRT) remains the conventional approach in locally advanced stages until the upcoming approval of immunotherapy. The incorporation of immunotherapy in combination with chemotherapy (with or without bevacizumab) in first line and as monotherapy in second line after platinum-based chemotherapy, has significantly increased overall survival (OS) in recurrent or metastatic CC. The purpose of this guideline is to summarize the most relevant evidence in the diagnosis, treatment, and follow-up of CC and to provide evidence-based recommendations for clinical practice.
Coll uterí - Càncer - Immunoteràpia, COMPUESTOS QUÍMICOS Y DROGAS::mezclas complejas::productos biológicos::vacunas::vacunas víricas::vacunas para papilomavirus, Other subheadings::Other subheadings::/therapy, Clinical Guides in Oncology, Uterine Cervical Neoplasms, Guideline, Medical Oncology, Vacunes antivíriques, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas::neoplasias del cuello uterino, Diagnosis, Humans, DISEASES::Virus Diseases::Virus Diseases::Tumor Virus Infections::Papillomavirus Infections, Papillomavirus Vaccines, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::tratamiento combinado::quimiorradioterapia, Societies, Medical, Neoplasm Staging, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Combined Modality Therapy::Chemoradiotherapy, Papillomavirus Infections, ENFERMEDADES::virosis::virosis::infecciones por virus oncógenos::infecciones por Papillomavirus, Chemoradiotherapy, Infeccions per papil·lomavirus - Tractament, Treatment, Otros calificadores::Otros calificadores::/terapia, DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Uterine Cervical Neoplasms, CHEMICALS AND DRUGS::Complex Mixtures::Biological Products::Vaccines::Viral Vaccines::Papillomavirus Vaccines, Cervical cancer, Female, Coll uterí - Càncer - Radioteràpia, Immunotherapy, Coll uterí - Càncer - Quimioteràpia
Coll uterí - Càncer - Immunoteràpia, COMPUESTOS QUÍMICOS Y DROGAS::mezclas complejas::productos biológicos::vacunas::vacunas víricas::vacunas para papilomavirus, Other subheadings::Other subheadings::/therapy, Clinical Guides in Oncology, Uterine Cervical Neoplasms, Guideline, Medical Oncology, Vacunes antivíriques, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas::neoplasias del cuello uterino, Diagnosis, Humans, DISEASES::Virus Diseases::Virus Diseases::Tumor Virus Infections::Papillomavirus Infections, Papillomavirus Vaccines, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::tratamiento combinado::quimiorradioterapia, Societies, Medical, Neoplasm Staging, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Combined Modality Therapy::Chemoradiotherapy, Papillomavirus Infections, ENFERMEDADES::virosis::virosis::infecciones por virus oncógenos::infecciones por Papillomavirus, Chemoradiotherapy, Infeccions per papil·lomavirus - Tractament, Treatment, Otros calificadores::Otros calificadores::/terapia, DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Uterine Cervical Neoplasms, CHEMICALS AND DRUGS::Complex Mixtures::Biological Products::Vaccines::Viral Vaccines::Papillomavirus Vaccines, Cervical cancer, Female, Coll uterí - Càncer - Radioteràpia, Immunotherapy, Coll uterí - Càncer - Quimioteràpia
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).10 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!